Detalles de la búsqueda
1.
Effects on Cancer Prevention from the COVID-19 Pandemic.
Annu Rev Med
; 75: 1-11, 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37625124
2.
Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision.
Gastroenterology
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552671
3.
Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis.
Gut
; 72(7): 1319-1325, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37076272
4.
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model.
Gut
; 72(1): 101-108, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35537811
5.
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program.
Int J Cancer
; 152(8): 1536-1546, 2023 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36444504
6.
Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening.
Clin Gastroenterol Hepatol
; 21(13): 3424-3432.e2, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37619823
7.
Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program.
Endoscopy
; 55(12): 1061-1069, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37793423
8.
Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
BMC Gastroenterol
; 23(1): 45, 2023 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814185
9.
Risk-stratified strategies in population screening for colorectal cancer.
Int J Cancer
; 150(3): 397-405, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34460107
10.
Effects of cancer screening restart strategies after COVID-19 disruption.
Br J Cancer
; 124(9): 1516-1523, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33723386
11.
The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.
Prev Med
; 151: 106643, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34217421
12.
When to Start, When to Stop With Colorectal Cancer Screening: A Cost-Effectiveness Analysis.
Gastroenterology
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762073
13.
Correction: Effects of cancer screening restart strategies after COVID-19 disruption.
Br J Cancer
; 125(1): 145, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33976368
14.
Rationale for organized Colorectal cancer screening programs.
Best Pract Res Clin Gastroenterol
; 66: 101850, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37852709
15.
Personalised colorectal cancer screening strategies: Information needs of the target population.
Prev Med Rep
; 35: 102325, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601828
16.
Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening.
EClinicalMedicine
; 62: 102081, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37538541
17.
Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
Eur J Cancer
; 190: 112942, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37406529
18.
Optimising colorectal cancer screening in Shanghai, China: a modelling study.
BMJ Open
; 12(5): e048156, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577474
19.
Cost-effectiveness analysis of colorectal cancer screening in Shanghai, China: A modelling study.
Prev Med Rep
; 29: 101891, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35864929
20.
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
J Med Screen
; 29(2): 72-83, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100894